Acute post-streptococcal glomerulonephritis (APSGN) in the Torres Strait and Cape York: surveillance insights pre- and post- mandatory notification
DOI:
https://doi.org/10.33321/cdi.2025.49.031Keywords:
acute post-streptococcal glomerulonephritis, glomerulonephritis, Streptococcus pyogenes, Indigenous health, First Nations health, Aboriginal and Torres Strait Islander health, kidney diseaseAbstract
Acute post-streptococcal glomerulonephritis (APSGN) is an immune-mediated kidney condition, typically affecting children. While the incidence has declined in urban Australia, APSGN remains a major concern in rural and remote communities, particularly among First Nations children. This study describes the epidemiology of APSGN in the Torres Strait and Cape York region of Far North Queensland (FNQ) over a three-year period, from January 2022 to December 2024, which spanned pre- and post-mandatory public health notification of APSGN in Queensland.
Cases were initially identified through electronic medical record alerts and later augmented by clinical notification when APSGN became notifiable in Queensland in October 2023. Over the three years of our study period, there were 75 confirmed, probable and possible cases identified, including outbreaks on Waiben (Thursday Island) and New Mapoon. The median age of cases was six years (interquartile range: 4–9 years), with 92% of cases occurring in children under 15, all from First Nations backgrounds. The 63 confirmed and probable cases in children under 15 represent an incidence within this population of 390 cases per 100,000 person-years (95% confidence interval: 294–486 per 100,000 person-years), ostensibly the highest documented rate globally.
In the modern era, the burden of this preventable disease for FNQ First Nations children is the highest in the world. Progress will only be made by addressing the underlying social determinants of health, including childhood disadvantage and household crowding.
Downloads
References
Balasubramanian R, Marks SD. Post-infectious glomerulonephritis. Paediatr Int Child Health. 2017;37(4):240–7. doi: https://doi.org/10.1080/20469047.2017.1369642.
Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5(11):685–94. doi: https://doi.org/10.1016/S1473-3099(05)70267-X.
Worthing KA, Lacey JA, Price DJ, McIntyre L, Steer AC, Tong SYC et al. Systematic review of group A streptococcal emm types associated with acute post-streptococcal glomerulonephritis. Am J Trop Med Hyg. 2019;100(5):1066–70. doi: https://doi.org/10.4269/ajtmh.18-0827.
Marshall CS, Cheng AC, Markey PG, Towers RJ, Richardson LJ, Fagan PK et al. Acute post-streptococcal glomerulonephritis in the Northern Territory of Australia: a review of 16 years data and comparison with the literature. Am J Trop Med Hyg. 2011;85(4):703–10. doi: https://doi.org/10.4269/ajtmh.2011.11-018.
Queensland State Government Department of Health (Queensland Health). Acute Post-Streptococcal Glomerulonephritis (APSGN). [Webpage.] Brisbane: Queensland Health; December 2023. Available from: https://www.health.qld.gov.au/cdcg/index/acute-post-streptococcal-glomerulonephritis-apsgn.
Dowler J, Wilson A. Acute post‐streptococcal glomerulonephritis in Central Australia. Aust J Rural Health. 2020;28(1):74–80. doi: https://doi.org/10.1111/ajr.12568.
Queensland State Government Register of Legislation (Queensland Legislation). Public Health Regulation 2018. [Legislation.] Brisbane: Office of the Queensland Parliamentary Counsel; 2018. Available from: https://www.legislation.qld.gov.au/view/html/inforce/current/sl-2018-0117.
Streeton CL, Hanna JN, Messer RD, Merianos A. An epidemic of acute post-streptococcal glomerulonephritis among Aboriginal children. J Paediatr Child Health. 1995;31(3):245–8. doi: https://doi.org/10.1111/j.1440-1754.1995.tb00795.x.
Queensland Health, Torres and Cape Hospital and Health Service (TCHHS). Torres and Cape Hospital and Health Service. [Website.] Cairns: TCHHS; 2024. Available from: https://www.torres-cape.health.qld.gov.au/.
Queensland Health Statistical Services Branch. InfoBank - Demography. [Queensland Health intranet page.] Brisbane: Queensland Health; 22 March 2024. [Accessed on 5 March 2025.] Available from: https://qheps.health.qld.gov.au/hsu/infobank/infobank-demography#estimated.
Jackson SJ, Steer AC, Campbell H. Systematic review: estimation of global burden of non-suppurative sequelae of upper respiratory tract infection: rheumatic fever and post-streptococcal glomerulonephritis. Trop Med Int Health. 2011;16(1):2–11. doi: https://doi.org/10.1111/j.1365-3156.2010.02670.x.
Chaturvedi S, Boyd R, Krause V. Acute post-streptococcal glomerulonephritis in the Northern Territory of Australia: a review of data from 2009 to 2016 and comparison with the literature. Am J Trop Med Hyg. 2018;99(6):1643–8. doi: https://doi.org/10.4269/ajtmh.18-0093.
Kimberley Aboriginal Health Planning Forum. Acute post-streptococcal glomerulonephritis (APSGN): evidence used and rationale. Broome: Kimberley Aboriginal Medical Services; 16 May 2024. Available from: https://static1.squarespace.com/static/5b5fbd5b9772ae6ed988525c/t/6698827c8a0523110e5551c8/1721270909019/APSGN_Kimberley_Clinical_Guideline_KAHPF_Evidence_Used_and_Rationale_endorsed_12072024.pdf.
Queensland Health. Notifiable conditions annual reporting. [Webpage.] Brisbane: Queensland Health; 2024. Available from: https://www.health.qld.gov.au/clinical-practice/guidelines-procedures/diseases-infection/surveillance/reports/notifiable/annual.
Satoskar AA, Parikh SV, Nadasdy T. Epidemiology, pathogenesis, treatment and outcomes of infection-associated glomerulonephritis. Nat Rev Nephrol. 2020;16(1):32–50. doi: https://doi.org/10.1038/s41581-019-0178-8.
Yeoh DK, Anderson A, Cleland G, Bowen AC. Are scabies and impetigo “normalised”? A cross-sectional comparative study of hospitalised children in northern Australia assessing clinical recognition and treatment of skin infections. PLoS Negl Trop Dis. 2017;11(7):e0005726. doi: https://doi.org/10.1371/journal.pntd.0005726.
Queensland Health, TCHHS. Strategic Plan 2023–2027. [Webpage.] Cairns: TCHHS; June 2023. Available from: https://www.torres-cape.health.qld.gov.au/about-us/corporate-publications-and-reporting/strategic-plan.
Qu L, Baxter J, Gorniak M. Population, households and families. [Webpage.] Melbourne: Australian Government, Australian Institute of Family Studies; July 2023. Available from: https://aifs.gov.au/research/facts-and-figures/population-households-and-families.
McDonald MI, Towers RJ, Andrews RM, Benger N, Currie BJ, Carapetis JR. Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian Aboriginal communities where acute rheumatic fever Is hyperendemic. Clin Infect Dis. 2006;43(6):683–9. doi: https://doi.org/10.1086/506938.
Lamagni TL, Darenberg J, Luca-Harari B, Siljander T, Efstratiou A, Henriques-Normark B et al. Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol. 2008;46(7):2359–67. doi: https://doi.org/10.1128/JCM.00422-08.
Scrace M, Koko K. An outbreak of acute post-streptococcal glomerulonephritis in remote Far North Queensland. Aust J Rural Health. 2006;14(4):160–3. doi: https://doi.org/10.1111/j.1440-1584.2006.00795.x.
Marmot M. The Health Gap: The Challenge of an Unequal World: the argument. Int J Epidemiol. 2017;46(4):1312–8. doi: https://doi.org/10.1093/ije/dyx163.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
